CYTEK BIOSCIENCES, INC. Deferred Federal Income Tax Expense (Benefit)
CYTEK BIOSCIENCES, INC. (CTKB) reported Deferred Federal Income Tax Expense (Benefit) of $28.14 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-02-26
- CYTEK BIOSCIENCES, INC. deferred federal income tax expense (benefit) for fiscal 2025 was $28.14M.
- CYTEK BIOSCIENCES, INC. deferred federal income tax expense (benefit) for fiscal 2024 was -$2.55M.
- CYTEK BIOSCIENCES, INC. deferred federal income tax expense (benefit) for fiscal 2023 was -$8.78M.
- CYTEK BIOSCIENCES, INC. deferred federal income tax expense (benefit) for fiscal 2022 was -$9.16M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $28.14M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$2.55M 10-K · filed 2026-02-26 |
| 2023-12-31 | -$8.78M 10-K · filed 2026-02-26 |
| 2022-12-31 | -$9.16M 10-K · filed 2025-02-28 |
| 2021-12-31 | -$2.53M 10-K · filed 2024-03-13 |
| 2020-12-31 | -$4.96M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |